Press & Publications
- 2022- Poster EASL NAFLD Summit September 2022
- 2022- Poster EASL June 2022
- 2021- CymaBay Pressrelease on the Seladelpar study in the NIF mouse
- 2021- CymaBay Poster on the NIF mouse at AASLD
- 2021- Poster EASL sept 2021
- 2021- Poster on NIF liver model»
- 2020- Publication on role of NKT cells in NIF liver fibrosis»
- 2019 – 2-pager on InfiCure Bio»
- 2019- The NIF mouse as a liver fibrosis model »
- 2018- Publication on treatment of liver fibrosis »
- 2016- Publication on liver phenotype »
Meeting with investors in New York
- 2017 – Preparation at Carnegie Investment Bank
- 2017 – Carnegie report from investor meeting in NYC
- 2017 – Interview with Sofia Mayans about investor meeting in NY
Cooperation with Connect
- 2018 – About collaboration with Connect (in Swedish)
- 2017 – InfiCure Bio 2016 Connect prize (in Swedish)
- 2017 – Affärsliv24 InfiCure Bio 2016 Connect prize (in Swedish)
- 2017 – Affärsliv24 InfiCure Bio 2016 Connect Company in northern Sweden (in Swedish)
- 2016 – Article Swedish Radio (SR) (In swedish)
- 2016 – Article Affärsliv24 (In swedish)
Competition SvD and Carnegie Investment Bank
- 2016 – Umebolag med transgen mus, Carnegie | Framtidens entreprenör (pdf)
- 2016 – http://www.svd.se/bolagen-som-kan-bli-jattesuccer–vilket-far-din-rost
- 2016 – http://www.svd.se/topp/framtidens-entreprenor-2016/inficure-bio
- 2016 – https://www.svd.se/finalister-klara-en-av-dessa-blir-framtidens-entreprenor#sida-3
- 2016 – http://www.svd.se/entreprenorsskap-ar-risktagande-och-frihet
- 2016 – https://www.carnegie.se/privatbank/Aktuellt/alldeles-nyss-slot-vi-avtal-med-var-forsta-usa-kund/
- 2016 – Public pitch competitions can be worthwhile
News about funding and clients
- 2023- Pressrelease on US deal
- 2022- Pressrelease on partnership with Innoser
- 2022-InfiCure Bio signs agreement with two
major international companies - 2020- US patent granted for the NIF mouse model
- 2020- Signed agreement with publically listed US biopharmaceutial company
- 2020 – News on new client in the US (in Swedish – vk24)
- 2019 – Nordic Life Science News reports on our new client in the US
- 2019 – News on new client in the US (in Swedish – vk24)
- 2019 – Additional funding from local investors
- 2019 – Nyhet om kund publicerad i Kemivärlden (in swedish)
- 2019 – Nyhet om kund i Schweiz (in Swedish – vk24)
- 2019 – News on client in Switzerland
- 2019 – News on funding from Vinnova – Innovationsprojekt i företag (in Swedish)
- 2018 – http://www.northernlightcapital.se/northern-light-investerar-i-inficure-bio/
- 2018 – News about agreement with CSL
- 2018 – Affärsliv24 Samarbete med CSL (in Swedish)
- 2018 – Lifescience Sweden om samarbetet med CSL (in Swedish)
- 2018 – Nordic Life Science news about collaboration with CSL
- 2017 – http://affarsliv24.vk.se/1963667/umeabolag-far-anslag-for-varldsunik-mus
- 2017 – https://www.va.se/nyheter/2017/03/24/varldsunik-musmodell-kan-bli-avgorande-for-nya-mediciner-owilli/
- 2017 – https://affarsliv24.vk.se/2107674/riskkapital-till-umeaforetag-stor-global-potential
- 2017 – http://www.ubi.se/news/pioneering-fibrosis-startup-secures-backing-to-reach-global-market
- 2017 – https://sme.easme-web.eu/?b=911458464
- 2016 – http://nordiclifescience.org/inficure-attracts-international-attention/
Other
- 2020 – Kemivärlden om anställning av Kajsa Linde (in Swedish)
- 2019 – Interview nominated companies in Vk (in Swedish)
- 2019 – Interview nominated companies in Folkbladet (in Swedish)
- 2019 – Nominering Årets nya företagare UmeåGalan 2019 (in Swedish)
- 2019 – Lena Söderström appointed Chairman of the Board (in Swedish)
- 2018 – Nominering Årets Avknoppningsföretag UmeåGalan 2018 (in Swedish)
- 2018 – Intervju nomineringsevent inför UmeåGalan 2018 (in Swedish)
- 2018 – Nominering till Umeågalan text av Uminova Innovation
- 2018 – Intervju angående nominering till Umeågalan (in Swedish)
- 2018 – InfiCure Bios CEO, Sofia Mayans, tells about her journey from phd-student to CEO (in Swedish)
- 2016 – http://affarsliv24.vk.se/1880374/de-prisas-av-kommunen-for-smart-arbete